How should I taper a patient off oxcarbazepine 300 mg twice daily?

Tapering Oxcarbazepine 300 mg BID

For patients discontinuing oxcarbazepine after long-term use, reduce the dose by approximately 10% per month or more slowly, extending the taper over several months to minimize withdrawal seizure risk. 1

Recommended Tapering Schedule

Starting from 600 mg/day (300 mg BID), reduce by approximately 60 mg per month:

• Month 1: Decrease to 540 mg/day (270 mg BID) 1
• Month 2: Decrease to 480 mg/day (240 mg BID) 1
• Month 3: Decrease to 420 mg/day (210 mg BID) 1
• Month 4: Decrease to 360 mg/day (180 mg BID) 1
• Month 5: Decrease to 300 mg/day (150 mg BID) 1
• Month 6: Decrease to 240 mg/day (120 mg BID) 1
• Continue reducing by 10% of the current dose monthly until discontinuation 1

For patients who have taken oxcarbazepine for ≥1 year, the total taper duration should extend over several months to years depending on treatment duration and individual tolerance. 1

Critical Monitoring Requirements

Schedule follow-up visits at least monthly throughout the taper to assess for breakthrough seizures and withdrawal symptoms. 1

Watch for signs of seizure recurrence or worsening:

• Increased seizure frequency or severity 1
• New seizure types 1
• Aura symptoms returning 1

If clinically significant withdrawal symptoms or breakthrough seizures occur, pause the taper or slow the reduction rate further. 1

Patient-Centered Approach

Collaborate with the patient on the tapering plan, including decisions about taper speed and when pauses may be warranted. 1

Patient agreement and active participation are essential for successful tapering outcomes. 1

When patients and clinicians cannot agree on taper necessity, acknowledge the discordance, express empathy, and pursue patient-centered adjustments without abandoning care. 1

Adjusting the Taper

Tapers may need to be paused and restarted when the patient is ready, and often must be slowed as lower doses are approached. 1

For patients struggling to tolerate the taper, maximize alternative seizure management strategies and address behavioral distress. 1

Before reversing a taper due to breakthrough seizures, carefully assess and discuss with the patient the benefits and risks of increasing the oxcarbazepine dose. 1

Alternative Antiepileptic Coverage

Optimize other antiepileptic therapies before and during the taper to maintain seizure control. 1

Consider initiating or increasing alternative antiepileptic drugs with favorable tolerability profiles (such as lamotrigine, levetiracetam, or lacosamide) before beginning the oxcarbazepine taper. 2

Safety Considerations

Never discontinue oxcarbazepine abruptly, as this significantly increases the risk of breakthrough seizures and status epilepticus. 1

Involve multidisciplinary team members (nurses, pharmacists) to support the patient through telephone contact, telehealth, or face-to-face visits during the taper. 1

Goals may vary—some patients may achieve complete discontinuation while others may reach a reduced maintenance dose that balances seizure control with tolerability. 1

Common Pitfalls to Avoid

Do not use a linear tapering schedule that maintains the same absolute dose reduction throughout—this creates disproportionately large percentage reductions at lower doses. 3

Avoid tapering faster than 10% per month in patients with long-term use (≥1 year), as this increases seizure recurrence risk. 1

Do not proceed with tapering if the patient is experiencing increased seizure frequency or severity on their current dose. 1